ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

DCCR Receives 59 Community Hospital Oncology Program Proposals, Only here From Rural Areas

September 21, 1979

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998

NCI funds 17 EDRN biomarker labs. Bush signs omnibus funding legislation.

December 10, 2004

Tough Year Seen for Cooperative Groups; Priority Payment Questioned

December 2, 1988

NCI CTEP Approved Trials For the Month of January

January 31, 2014